Blood 25-Hydroxyvitamin D3 Concentrations and Incident Sporadic Colorectal Adenoma Risk: A Pooled Case-Control Study

Plasma 25-Hydroxyvitamin D Levels and the Risk of Colorectal Cancer: The Multiethnic Cohort Study

(2010) C. G. Woolcott et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Comparing Methods for Accounting for Seasonal Variability in a Biomarker When Only a Single Sample Is Available: Insights From Simulations Based on Serum 25-Hydroxyvitamin D

(2009) Yiting Wang et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

MutL-Homolog 1 Expression and Risk of Incident, Sporadic Colorectal Adenoma: Search for Prospective Biomarkers of Risk for Colorectal Cancer

(2009) E. Sidelnikov et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

TGF-  Expression as a Potential Biomarker of Risk Within the Normal-appearing Colorectal Mucosa of Patients with and without Incident Sporadic Adenoma

(2009) C. R. Daniel et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Vitamin D and Prevention of Colorectal Adenoma: A Meta-analysis

(2008) M. Y. Wei et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Selective inhibition of cyclooxygenase-2 (COX-2) by 1α,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog

(2008) Rachamallu Aparna et al.   JOURNAL OF CELLULAR BIOCHEMISTRY